Life ScienceCompany
Where is Efimosfermin headquartered?
Efimosfermin is headquartered in Cambridge, Massachusetts.
What sector is Efimosfermin in?
Efimosfermin is a life science company.
Efimosfermin is headquartered in Cambridge, Massachusetts.
Efimosfermin is a life science company.
Efimosfermin is a novel, once-monthly fibroblast growth factor 21 analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis, including cirrhosis, and future development in alcohol-related liver disease. Efimosfermin is based in Cambridge, Massachusetts.
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.